Patient profile
Medications, labs, conditions, and history are organized.
Before AIME 2026
Closing the Guideline Implementation Gap
Trusted clinical intelligence for cardiovascular, kidney, and diabetes care.
GDMT.ca combines pharmacist expertise, deterministic clinical logic, structured patient data, and responsible artificial intelligence to help identify, prioritize, document, and implement guideline-directed medical therapy in real-world clinical practice.
The Challenge
Implementation remains the bottleneck.
Cardiovascular disease, chronic kidney disease, and diabetes remain among the most important drivers of preventable morbidity, mortality, and healthcare utilization. Evidence-based therapies exist, but many eligible patients do not consistently receive guideline-directed medical therapy. The challenge is no longer only discovering effective treatments. The challenge is implementing them reliably.
Why this matters
Complex multimorbidityPatients often span cardiovascular, kidney, diabetes, and lipid domains simultaneously.
Fragmented dataMedication history, lab trends, and clinical context are rarely assembled cleanly.
Workflow pressureClinicians need actionable implementation support rather than generic AI advice.
The GDMT.ca Solution
Patient profile to implementation tracking
Deterministic checks
Structured data, thresholds, and rule-based logic are handled by software.
AI-assisted review
Draft documentation and validation-ready outputs are generated.
Pharmacist validation
Human oversight remains central before communication and follow-up.
Built Around Trust
Designed for accountable clinical use
Canadian guideline alignment
Built around guideline-directed therapy opportunities relevant to Canadian pharmacist practice.
Deterministic clinical logic
Structured data parsing, thresholds, safety gates, and rule checks remain deterministic wherever possible.
Responsible AI
AI assists clinical documentation, review, validation, and implementation support. It does not replace judgment.
Pharmacist oversight
Human pharmacist review remains mandatory before recommendations are documented, communicated, or acted upon.
Clinical Focus
High-impact chronic disease implementation
ASCVD
Support for secondary prevention and lipid management opportunities.
Chronic Kidney Disease
Albuminuria interpretation, cardiorenal therapy sequencing, and monitoring readiness.
Diabetes
Medication optimization and guideline-directed risk reduction support.
Heart Failure
Therapy sequencing, safety checks, and pharmacist-ready communication support.
Dyslipidemia
Threshold-based risk management, referral triggers, and recommendation support.
Medication Optimization
Monitoring gaps, sequencing conflicts, and implementation-focused review across multimorbidity.
Why GDMT.ca is Different
Implementation-first, not automation-first.
GDMT.ca helps pharmacists translate evidence into actionable, physician-ready and patient-friendly clinical communication while preserving human accountability and professional judgment.